Pharma Audit Trail Review: Scope, Frequency and Evidence

A pharma audit trail review does not mean examining every technical event. It focuses on changes, deletions and actions that could affect a GxP record or quality decision. Scope, frequency and reviewer roles follow data criticality, process risk and existing controls. The evidence should show what was reviewed, which exceptions were investigated and who approved the assessment.

Why an available audit trail is not yet an effective control

Your system produces thousands of entries. Quality requires a regular review, while operations cannot manually assess every login, technical status change and background message. A broad requirement can therefore become an unmanageable routine.

The answer is not less control. It is a technically and procedurally justified scope. Start with the regulated record and the quality decision. Then identify the audit trail events needed to protect them.

FDA links audit trail review to review of the associated CGMP record. Where regulations specify a record-review frequency, the same frequency applies to its audit trail. Where no frequency is specified, the organisation should use data criticality, existing controls and potential product impact.

Effective EU GMP Annex 11 calls for a risk-based assessment of whether an audit trail should be built into the system for GMP-relevant changes and deletions. Existing audit trails need to be convertible to an intelligible form and regularly reviewed. Where 21 CFR Part 11 applies to an electronic record, § 11.10(e) requires a secure, computer-generated, time-stamped audit trail. PIC/S PI 041-1 further calls for clear identification of critical data and the changes that must be recorded.

Separate data audit trails, system logs and security records

Not every log serves the same purpose. Without separation, review volume rises while decision value falls.

Record type	Typical content	Review purpose
Data audit trail	Creation, change or deletion of a GxP record; old and new value; reason	Assess impact on data integrity and the quality decision
Configuration audit trail	Roles, workflows, calculation rules, master data or system settings	Detect unexpected or unapproved system changes
Security or system log	Login, failed access, technical jobs, interface errors	Monitor security and operational risk
Support and supplier log	Remote access, ticket, privileged activity	Reconcile external intervention with system and quality evidence

A technical log may matter for periodic security review without belonging to every batch or laboratory-result review. Conversely, an event relevant to a GxP record cannot be ignored because it resides in a separate technical log.

The article on electronic batch record validation explains how supplier interventions create this cross-system evidence challenge.

Build audit trail review in five steps

1. Prioritise GxP records and quality decisions

Do not begin with a list of log files. Begin with records whose integrity matters for product quality, patient safety or release.

These may include laboratory results, electronic batch records, approvals, specifications, critical master data or quality-relevant calculations. For each record, define relevant changes, deletions, repetitions and status transitions.

2. Define significant events and exceptions

The review rule needs specific criteria. Examples include changes after business approval, deleted results, repeat testing, missing change reasons, privileged actions or changes outside the intended workflow.

Process owners, the system owner and Quality should agree these criteria. The reviewer can then assess business impact rather than simply count technical events.

3. Connect frequency to the record lifecycle

Critical changes may need review before record approval or release. Other events may fit a periodic review.

A defensible frequency decision considers:

• the regulatory or procedural review of the associated record;
• data criticality and potential product impact;
• technical prevention and the access model;
• event volume, change rate and previous exceptions;
• additional controls such as second-person verification, deviation management and access review.

“Monthly” or “quarterly” is only a calendar entry without this rationale. The risk logic belongs in the procedure or system-specific assessment.

4. Validate review by exception

An exception report can focus the review. It does not replace professional assessment. The organisation must demonstrate that filters, queries and thresholds completely and correctly identify relevant events.

Validation includes positive and negative cases. The report should display known critical changes and exclude irrelevant events in a justified manner. Changes to filters, roles or data sources remain under change control.

5. Close reviewer evidence and escalation

The record should identify the period, system, record scope, query, result, exceptions, actions, reviewer and date. A simple “reviewed” checkbox is not sufficient for complex events.

The reviewer needs process knowledge, system access and defined independence from the activity under review. Exceptions are linked to deviations, investigations, CAPA or change control where appropriate.

What defensible review evidence contains

An inspector should be able to reconstruct the decision chain. A compact review record therefore covers:

1. Scope: Which records, fields, events and time periods were included?
2. Method: Which system view, query or validated exception function was used?
3. Result: How many events were identified and which were significant?
4. Assessment: What was the impact on the record, batch, product or release?
5. Action: Which deviation, CAPA or technical change followed?
6. Approval: Who reviewed and who approved the assessment?

This structure connects technical evidence with the quality decision. It also supports GxP audit readiness because the rationale does not need to be reconstructed immediately before an inspection.

Three common weak approaches

Review everything. Complete manual log review appears strict but can bury significant events in excessive volume. A justified scope with validated exceptions is stronger.

Review only the system log. Login and operational events do not replace review of changes to the regulated record.

Approve the report without process context. An event becomes meaningful through its potential effect. Reviewers therefore need record, process and quality context.

Recurring inspection observations are discussed in the article on FDA warning letters and data integrity.

Frequently asked questions

Must every audit trail entry be reviewed before each release?

No. Frequency follows the associated record review or a documented risk assessment. Critical data changes may require review with the record. Technical events without a direct record link may belong to a justified periodic review.

Can an exception report replace manual review?

A validated exception report can automate selection of relevant events. Professional assessment and the documented decision remain necessary. Filters, data sources and change control for the report must be demonstrably controlled.

Who should review the audit trail?

The reviewer needs sufficient process, data and system knowledge as well as access to the relevant record. The role model should avoid conflicts of interest. For CGMP records, FDA connects audit trail review with the responsible record and quality reviews.

Primary sources

• FDA: Data Integrity and Compliance With Drug CGMP — Questions and Answers
• eCFR: 21 CFR Part 11 § 11.10 — Controls for closed systems
• EU GMP Annex 11: Computerised Systems, effective 2011 version
• PIC/S PI 041-1: Guidance on Data Integrity

---

Author

Daniel Herrmann Consulting — boutique consultancy for GxP compliance and Computer System Validation in pharma, biotech and MedTech. 15+ years of hands-on expertise. 60+ validated systems. 100 % audit pass rate. 0 critical findings.